3PO

别名: 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one

目录号：S7639 Purity: 99.94%

3PO (3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one)是PFKFB3的小分子抑制剂，对人源重组PFKFB3蛋白的IC50为22.9 μM，而且不抑制PFK-1活性。它能够抑制葡萄糖吸收、减少胞内Fru-2,6-BP, lactate, ATP, NAD+ 和 NADH的浓度。

3PO Chemical Structure

CAS: 18550-98-6

规格	价格	库存
10mM (1mL in DMSO)	958.23	现货
5mg	794.88	现货
25mg	1859.38	现货
100mg	3849.85	现货
更大包装有超大折扣
400-668-6834 info@selleck.cn

产品质控

批次：纯度： 99.94%

99.94

3PO相关产品

相关靶点	PFKFB3 PFKFB4	点击展开
相关产品	PFK15 PFK158 KAN0438757	点击展开
相关化合物库	激酶抑制剂库 PI3K/Akt 抑制剂库 MAPK抑制剂库 DNA损伤/ DNA修复化合物库细胞周期化合物库	点击展开

细胞实验数据示例

细胞系	实验类型	给药浓度	孵育时间	活性描述	文献信息(PMID)
Jurkat	Cell proliferation assay	10 uM	36 hrs	Inhibition of cell proliferation of human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM incubated for 36 hrs by trypan blue dye exclusion assay	ChEMBL
Jurkat	Function assay	10 uM	4 hrs	Reduction in Fru-2,6-BP production in human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM measured within 4 hrs	ChEMBL
Jurkat	Function assay	10 uM	8 hrs	Reduction in lactate secretion in human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM after 8 hrs by lactate oxidase based colorimetric assay	ChEMBL
Jurkat	Function assay	10 uM	16 hrs	Reduction in NADH level in human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM after 16 hrs	ChEMBL
Jurkat	Function assay	10 uM	24 hrs	Reduction in NAD+ level in human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM after 24 hrs	ChEMBL
Jurkat	Function assay	10 uM	24 hrs	Reduction in ATP level in human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM after 24 hrs	ChEMBL
Jurkat	Function assay	10 uM	36 hrs	Suppression of glycolytic flux into lactate in human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM after 36 hrs by NMR spectroscopy	ChEMBL
NHBE	Growth inhibition assay	1 uM	48 to 72 hrs	Growth inhibition of human NHBE cells immortalized with human telomerase and large-T antigen and transformed with mutated Ras protein at 1 uM incubated for 48 to 72 hrs by trypan blue dye exclusion assay	ChEMBL
NHBE	Growth inhibition assay	10 uM	48 to 72 hrs	Growth inhibition of human NHBE cells immortalized with human telomerase and large-T antigen and transformed with mutated Ras protein at 10 uM incubated for 48 to 72 hrs by trypan blue dye exclusion assay	ChEMBL
Jurkat	Function assay	10 uM		Reduction in 2-deoxy-glucose uptake in human Jurkat cells expressing inducible FLAG-tagged PFKFB at 10 uM measured within 4 hrs using [14C]-2-deoxy-glucose by scintillation counting method	ChEMBL
Jurkat	Growth inhibition assay		48 hrs	Growth inhibition of human Jurkat cells expressing inducible FLAG-tagged PFKFB incubated for 48 hrs by trypan blue dye exclusion assay, IC50=1.4μM	ChEMBL
NHBE	Growth inhibition assay		48 to 72 hrs	Growth inhibition of human NHBE cells immortalized with human telomerase and large-T antigen and transformed with mutated Ras protein incubated for 48 to 72 hrs by trypan blue dye exclusion assay, IC50=1.5μM	ChEMBL
K562	Growth inhibition assay		48 hrs	Growth inhibition of human K562 cells incubated for 48 hrs by trypan blue dye exclusion assay, IC50=3.2μM	ChEMBL
HL60	Growth inhibition assay		48 hrs	Growth inhibition of human HL60 cells incubated for 48 hrs by trypan blue dye exclusion assay, IC50=4.5μM	ChEMBL
MDA-MB-231	Growth inhibition assay		48 hrs	Growth inhibition of human MDA-MB-231 cells incubated for 48 hrs by trypan blue dye exclusion assay, IC50=4.7μM	ChEMBL
Jurkat	Growth inhibition assay		48 hrs	Growth inhibition of human Jurkat cells expressing un-altered PFKFB expression incubated for 48 hrs by trypan blue dye exclusion assay, IC50=8.9μM	ChEMBL
CRL11174	Growth inhibition assay		48 hrs	Growth inhibition of human CRL11174 cells incubated for 48 hrs by trypan blue dye exclusion assay, IC50=15μM	ChEMBL
LLC	Growth inhibition assay		48 hrs	Growth inhibition of mouse LLC cells incubated for 48 hrs by trypan blue dye exclusion assay, IC50=19μM	ChEMBL
Jurkat	Growth inhibition assay		48 hrs	Growth inhibition of human Jurkat cells expressing inducible FLAG-tagged PFKFB in presence of doxycycline incubated for 48 hrs by trypan blue dye exclusion assay, IC50=19.3μM	ChEMBL
HeLa	Growth inhibition assay		48 hrs	Growth inhibition of human HeLa cells incubated for 48 hrs by trypan blue dye exclusion assay, IC50=24μM	ChEMBL
Jurkat	Growth inhibition assay		48 hrs	Growth inhibition of PFKFB3+/-ht/LT/Ras human Jurkat cells and incubated for 48 hrs by trypan blue dye exclusion assay, IC50=26μM	ChEMBL
A549	Growth inhibition assay		48 hrs	Growth inhibition of human A549 cells incubated for 48 hrs by trypan blue dye exclusion assay, IC50=48μM	ChEMBL
Jurkat	Growth inhibition assay		48 hrs	Growth inhibition of PFKFB3+/+ht/LT/Ras human Jurkat cells and incubated for 48 hrs by trypan blue dye exclusion assay, IC50=49μM	ChEMBL
Jurkat	Cell cycle assay			Inhibition of cell cycle arrest in human Jurkat cells expressing inducible FLAG-tagged PFKFB assessed as accumulation at G2/M phase by propidium iodide staining based flow cytometry	ChEMBL
点击查看更多细胞系数据

生物活性

产品描述

靶点

PFKFB3 ^[2]

22.9 μM

体外研究(In Vitro)
体外研究活性	3PO主要通过与Fru-6-P竞争，抑制PFKFB3，而不抑制纯化的PFK-1活性。在多种人源恶性血液肿瘤和癌细胞系中，3PO可显著地减缓其细胞增殖(IC50=1.4-24 μM)。相较于正常的人类气道上皮细胞，3PO选择性对转染了ras的气道上皮细胞具有抑制生长作用。3PO可引起细胞周期G2-M期阻滞^[1]。
细胞实验	细胞系	Jurkat细胞
	浓度	10 μM
	孵育时间	0, 4, 8, 16, 24, 36 h
	方法	将Jurkat细胞以1 × 10⁵/mL密度铺于含10%胎牛血清和50 μg/mL gentamicin sulfate的RPMI 1640培养基中。用vehicle或10 μM 3PO处理细胞，处理时间为0, 4, 8, 16, 24 或 36 h。然后分析其细胞周期。

体内研究(In Vivo)
体内研究活性	向携瘤小鼠腹腔注射0.07 mg的3PO，3PO的给药显著减少了其胞内Fru-2,6-BP的浓度、葡萄糖吸收以及肿瘤的生长。它可抑制乳腺癌、白血病和肺癌细胞的肿瘤生长^[1]。向C57Bl/6小鼠静脉注射3PO，检测其在体内药代动力学参数：CL=2312 mL/min/kg, T_1/2=0.3 hr, C_max=113 ng/ml, AUC_0-inf=36 ng/hr/ml。在白血病高度相关的小鼠模型中，3PO具有有效抗肿瘤活性^[2]。
动物实验	Animal Models	携瘤小鼠(BALB/c裸鼠或C57Bl/6小鼠)
	Dosages	0.07 mg/g
	Administration	i.p.

参考文献
https://pubmed.ncbi.nlm.nih.gov/18202014/ https://pubmed.ncbi.nlm.nih.gov/23674815/

参考文献

https://pubmed.ncbi.nlm.nih.gov/18202014/
https://pubmed.ncbi.nlm.nih.gov/23674815/

化学信息&溶解度

分子量	210.23	分子式	C₁₃H₁₀N₂O
CAS号	18550-98-6	SDF	Download 3PO SDF
Smiles	C1=CC(=CN=C1)C=CC(=O)C2=CC=NC=C2
储存条件(自收到货起)	3年-20°C粉状	储备液保存和期限建议分装储备液，避免反复冻融！	1年-80°C溶于溶剂
储存条件(自收到货起)	3年-20°C粉状	储备液保存和期限建议分装储备液，避免反复冻融！	1个月-20°C溶于溶剂

体外溶解度
批次：

DMSO : 42 mg/mL ( (199.78 mM) ；DMSO吸湿会降低化合物溶解度，请使用新开封DMSO)

Ethanol : 11 mg/mL (52.32 mM)

Water : Insoluble

DMSO : 42 mg/mL ( (199.78 mM) ；DMSO吸湿会降低化合物溶解度，请使用新开封DMSO)

Ethanol : 42 mg/mL (199.78 mM)

Water : Insoluble

DMSO : 42 mg/mL ( (199.78 mM) ；DMSO吸湿会降低化合物溶解度，请使用新开封DMSO)

Ethanol : 10 mg/mL (47.56 mM)

Water : Insoluble

摩尔浓度计算器

体内溶解配方批次：现配现用，请按从左到右的顺序依次添加，澄清后再加入下一溶剂				动物体内配方计算器
均匀悬浊液	CMC-NA	≥5mg/ml	以 1 mL 工作液为例，取 5 mg该产品加到 1 ml CMC-NA 溶液中，混合均匀，即可得工作液浓度为 5 mg/ml的均匀悬浊液。
澄清溶液	10%DMSO 1 40%PEG300 2 5%Tween80 3 45%ddH2O 该配方已经过Selleck实验室实测。如果上述溶解方案不能满足您的需求，可联系Selleck销售提供定制化测试。	7.000mg/ml (33.30mM)	以 1 mL 工作液为例，取100μL70mg/ml的澄清DMSO储备液加到400μL PEG300中，混合均匀使其澄清；向上述体系中加入50μLTween80，混合均匀使其澄清；然后继续加入450μL ddH2O定容至 1 mL。工作液请现配现用！
均匀悬浊液	CMC-NA	≥5mg/ml	以 1 mL 工作液为例，取 5 mg该产品加到 1 ml CMC-NA 溶液中，混合均匀，即可得工作液浓度为 5 mg/ml的均匀悬浊液。
均匀悬浊液	CMC-NA	≥5mg/ml	以 1 mL 工作液为例，取 5 mg该产品加到 1 ml CMC-NA 溶液中，混合均匀，即可得工作液浓度为 5 mg/ml的均匀悬浊液。

实验计算

摩尔浓度计算器

质量	浓度	体积	分子量
=	×	×

稀释计算器分子量计算器

动物体内配方计算器（澄清溶液）

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 μL 动物数量只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）

% DMSO + % + % Tween 80 + % ddH2O

%DMSO+ %

计算结果：

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于μL DMSO溶液（母液浓度mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；

体内配方配制方法：取μL DMSO母液，加入μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入μL ddH₂O，混匀澄清。

体内配方配制方法：取μL DMSO母液，加入μL Corn oil，混匀澄清。

注意：1. 首先保证母液是澄清的；
2.一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

* 必填项

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):